Individual Sections| Overview of Section Contents (Download) | 2015-02-11 | 213.33 KB |
| Table of Contents (Download) | 2013-09-27 | 273.45 KB |
| Section 01: Introduction (Download) | 2015-02-11 | 113.68 KB |
| Section 02: Documentation Requirements (Download) | 2015-02-11 | 207.27 KB |
| Section 03: Participant Accrual, Screening and Enrollment (Download) | 2015-02-11 | 220.51 KB |
| Section 04: Informed Consent (Download) | 2013-09-27 | 292.98 KB |
| Section 05: Participant Follow-up and Retention (Download) | 2014-06-16 | 204.27 KB |
| Section 06: Study Product Considerations for Non-Pharmacy Staff (Download) | 2013-09-27 | 277.27 KB |
| Section 07: Clinical Considerations (Download) | 2015-02-11 | 223.19 KB |
| Section 08: Adverse Event Reporting and Safety Monitoring (Download) | 2014-05-13 | 288.66 KB |
| Section 09: Counseling Considerations (Download) | 2015-02-11 | 228.1 KB |
| Section 10: Laboratory Considerations (Download) | 2014-05-13 | 1.01 MB |
| Section 11: Data Collection (Download) | 2014-05-14 | 937.9 KB |
| Section 12: Data Communiqués (Download) | 2013-09-27 | 233.15 KB |
| Section 12: MTN-024/IPM 031 Data Communiqué #1 (Download) | 2014-03-20 | 300.81 KB |
| Section 12: MTN-024/IPM 031 Data Communiqué #2 (Download) | 2014-06-20 | 341.78 KB |
| Section 13: Study Reporting Plan (Download) | 2013-09-27 | 418.57 KB |
| Section 14: Behavioral Measures (Download) | 2014-07-21 | 406.89 KB |
